A Study of AK112 for Advanced Solid Tumors
NCT04597541
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
59
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor, Adult
Interventions
DRUG:
AK112
Sponsor
Akeso